US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

RJVA-002 is a locally administered AAV9 viral vector that expresses human GIP and GLP-1 hormones from a human insulin promoter. We are confident that our novel pipeline will position us among the ...